Efficacy of neoadjuvant CapeOX/mFOLFOX6 without radiation for patients with baseline resectable mid-low locally advanced rectal cancer.

Xuan Zhao,Zi Rui He,Pei Yi Han,Zheng Hao Cai,Zhan Wei Fu,Lu Yang Zhang,Jing Sun,Jun Jun Ma,Feng Dong,Lu Zang,Min Hua Zheng

Journal of digestive diseases（2022）

引用 0|浏览9

暂无评分

摘要

The nCT has shown promising tumor response and survival outcomes, which can be a treatment option for baseline resectable LARC. For the two regimens, mFOLFOX6 provided better TRG than CapeOX, although no differences were observed in disease-free survival and OS.

查看译文

关键词

chemotherapy,laparoscopic surgery,neoadjuvant therapy,rectal neoplasms

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要